https://clinicaltrials.gov/ct2/show/NCT03575871?type=Intr&cond=Eczema&phase=0124&lupd_s=09%2F09%2F2019&lupd_d=14&sort=nwst
STUDY TITLE:
Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis
DESCRIPTION:
Condition: Dermatitis, Atopic
Interventions: Drug: PF-04965842 100 mg; Drug: PF-04965842 200 mg; Drug: Placebo
Sponsor: Pfizer
Completed
CLINICALTRIALS.GOV IDENTIFIER:
NCT03575871
FIRST POSTED:
Tue, 03 Jul 2018 12:00:00 EDT
LAST UPDATE POSTED:
09/23/19 07:49AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03575871?type=Intr&cond=Eczema&phase=0124&lupd_s=09%2F09%2F2019&lupd_d=14&sort=nwst
